期刊文献+

人类免疫缺陷病毒/艾滋病患者中和抗体保守表位氨基酸变异研究

Study on amino acid mutations in conserved neutralization epitopes in HIV-infected individuals and AIDS patients in China
原文传递
导出
摘要 目的探讨人类免疫缺陷病毒/艾滋病(HIV/AIDS)患者中和抗体保守表位氨基酸变异特征,为开展中和抗体免疫治疗和疫苗设计奠定理论基础。方法RTPCR及nestPCR扩增HIV/AIDS患者HIV1外膜envC2~C3区基因,双脱氧终止法进行核酸序列测定,翻译为氨基酸序列,并与HIV1SequenceDatabase参考毒株中和抗体表位数据比对辨别其保守表位氨基酸突变情况。结果HIV1外膜蛋白gp120C2~C3区,HIV感染者和AIDS患者CD4结合位点(CD4BS)、CD4诱导(CD4i)、2G12三种类型中和抗体保守表位氨基酸均存在突变,两组病例表位突变率差异无统计学意义(均P>0.05);CD4BS保守表位突变有370E/Q(12.1%),370E/K(4.5%),266A/S(1.5%),368D/E(1.5%);CD4i保守表位突变有370E/Q(12.1%),370E/K(4.5%),381E/D(7.6%),381E/V(1.5%);2G12保守表位突变有295N/V(19.7%),295N/T(6.1%),295N/D、295N/K、295N/E(各1.5%),297T/I(9.1%),297T/S、297T/N(各1.5%)。结论我国HIV/AIDS患者HIV1外膜蛋白gp120C2~C3区中和抗体CD4BS、CD4i、2G12保守表位氨基酸均存在突变,但尚处于低突变水平;不同类型中和抗体保守表位各氨基酸位点的变异程度有差异。 Objective To study the amino acid mutations in conserved neutralization epitopes in HIV-infected individuals and AIDS patients in China. Hopefully this will provide a basis for the neutralizin gantibodies immunotherapy and the design of vaccines. Methods RT-PCR and nest-PCR methods were used to amplify genes in the HIV-1 env C2-C3 region. Nucleic acids sequence were detected by double-deoxygen terminal method and translated into amino acids for analysis. The mutations of conserved neutralization epitopes were identified by comparison with the epitopes reference data in HIV-1 Sequence Database. Results Both HIV-infected individuals and AIDS patients demonstrated that there were three types conserved neutralization epitope mutations on HIV-1 gpl20 C2-C3 region, including: CI4-binding site (CIMBS),CI4-induced (CI4i) and 2G12. The mutation rates showed no significant difference (P 〉0. 05). CI4BS conserved neutralization epitope mutations focused on 370E/Q (12. 1%), 370E/K (4.5%), 266A/S(1.5%) and 368D/E (1.5%). CD4i conserved neutralization epitope mutations focused on 370E/Q ( 12. 1% ), 370E/K (4. 5% ) , 381E/D (7.6%) and 381E/V ( 1.5% ). 2G12 conserved neutralizationepitope mutations focused on 295N/V( 19. 7% ), 295N/T (6. 1% ) , 295N/D( 1.5% ) , 295N/K( 1.5% ) ,295N/E(1.5%), 297 T/I(9.1%), 297T/S(1.5%) and 297T/N(1.5%).Conclusion In both HIVinfected individuals and AIDS patients in China demonstrated a low level mutations in three types conserved neutralization epitope identified on HIV-1 gpl20 C2-C3 region, including: CD4BS, CD4i and 2G12. The mutation degrees of amino acids in conserved neutralization epitopes were different.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2005年第7期706-709,共4页 Chinese Journal of Laboratory Medicine
基金 "国家十五"科技攻关课题资助项目(2004BA719A12) 国家自然科学基金资助项目(30471548)
关键词 人类免疫缺陷病毒 艾滋病 中和抗体 保守表位 氨基酸变异 HIV Acquired immunodeficiency syndrome Amino acids
  • 相关文献

参考文献11

  • 1胡喜晨.HIV抗体检测初筛体检中假阳性原因分析及处理[J].中国误诊学杂志,2002,2(2):249-249. 被引量:6
  • 2Dennis R. Burton. Antibodies, viruses and vaccines. Nat Rev Immunol,2002, 2:706-713.
  • 3Rollman E, Hinkula J, Arteaga J,et al. Multi-subtype gp160 DNA immunization induces broadly neutralizing anti-HIV antibodies. Gene Ther, 2004,11:1146-1154.
  • 4Mascola JR. Defining the protective antibody response for HIV-1.Curt Mol Med, 2003, 3:209-216.
  • 5Agrawal L, Haq W, Hanson CV, et al. Generating neutralizing antibodies, Thl response and MHC non restricted immunogenicity of HIV-I env and gag peptides in liposomes and ISCOMs with in-built adjuvanticity. J Immune Based Ther Vaccines, 2003,1:5.
  • 6Wei X, Decker JM, Wang S, et al . Antibody neutralization and escape by HIV-1. Nature, 2003,422: 307-312.
  • 7Wyatt R, Kwong PD, Desjardins E, et al. The antigenic structure of the HIV gp120 envelope glycoprotein. Nature, 1998, 393: 705-711.
  • 8Moore J P, Sodroski J. Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein. J Virol, 1996, 70: 1863-1872.
  • 9Thali M, Furman C, Ho DD, et al. Discontinuous, conserved neutralization epitopes overlapping the CD4 binding region of the H1V-1 gp120 envelope glycoprotein. J Virol,1992, 66 : 5635-5641.
  • 10Ho DD, Mckeating JA, Li XL, et al. Conformational epitope on gp120 important in CIM binding and human immuno-deficiency virus type 1 neutralization identified by a human monoclonal antibody. J Virol,1991, 65:489-493.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部